AJP - Regulatory, Integrative and Comparative Physiology, Vol 271, Issue 1 276-R281, Copyright © 1996 by American Physiological Society

ARTICLES

Cardiac output and renal function during insulin hypertension in Sprague-Dawley rats

M. W. Brands, W. F. Lee, H. L. Keen, M. Alonso-Galicia, D. H. Zappe and J. E. Hall
Department of Physiology and Biophysics, University of Mississippi Medical Center, Jackson 39216-4505, USA.

Hyperinsulinemia has been reported to cause hypertension in rats; however, the renal and hemodynamic mechanisms are not known. In this study, changes in renal function, cardiac output (CO), and total peripheral resistance (TPR) were measured during chronic insulin infusion in eight rats (approximately 350 g). After a 4-day control period, a 7-day insulin infusion was begun (1.5 mU.kg-1.min-1 iv), together with glucose (22 mg.kg-1.min-1 iv) to prevent hypoglycemia. Mean arterial pressure (MAP), CO, TPR, and heart rate were measured 24 h/day. MAP increased from 92 +/- 1 to 100 +/- 2 mmHg on day 1 and was 108 +/- 4 mmHg by day 7 of insulin. CO tended to decrease during insulin infusion, although not significantly, averaging 94 +/- 4% of the control value of 121 +/- 7 ml/min. Heart rate did not change significantly from the control value of 384 +/- 8 beats/min. TPR increased significantly to 122 +/- 11% of control by day 7. In five rats, glomerular filtration rate and effective renal plasma flow decreased to 73 +/- 4 and 66 +/- 5% of control, respectively, during insulin. Urinary sodium excretion averaged 2.6 +/- 0.1 and 2.7 +/- 0.1 meq/day during the control and insulin-infusion periods, respectively. These results indicate that insulin hypertension in rats is initiated by an increase in TPR rather than by increased CO. Also, the fact that sodium balance was maintained at elevated arterial pressure suggests that the ability of the kidneys to excrete sodium was impaired chronically during insulin infusion.

This article has been cited by other articles:

				L. Nordquist, E. Y. Lai, M. Sjoquist, A. Patzak, and A. E. G. Persson Proinsulin C-peptide constricts glomerular afferent arterioles in diabetic mice. A potential renoprotective mechanism Am J Physiol Regulatory Integrative Comp Physiol, March 1, 2008; 294(3): R836 - R841. [Abstract] [Full Text] [PDF]

				N. Tian, R. S. Moore, S. Braddy, R. A. Rose, J.-W. Gu, M. D. Hughson, and R. D. Manning Jr. Interactions between oxidative stress and inflammation in salt-sensitive hypertension Am J Physiol Heart Circ Physiol, December 1, 2007; 293(6): H3388 - H3395. [Abstract] [Full Text] [PDF]

				N. Tian, A. W. Gannon, R. A. Khalil, and R. D. Manning Jr. Mechanisms of salt-sensitive hypertension: role of renal medullary inducible nitric oxide synthase Am J Physiol Regulatory Integrative Comp Physiol, February 1, 2003; 284(2): R372 - R379. [Abstract] [Full Text] [PDF]

				M. W. Brands, A. E. Hailman, and S. M. Fitzgerald Long-Term Glucose Infusion Increases Arterial Pressure in Dogs With Cyclooxygenase-2 Inhibition Hypertension, February 1, 2001; 37(2): 733 - 738. [Abstract] [Full Text] [PDF]

				C. R. Claxton, M. W. Brands, S. M. Fitzgerald, and J. A. Cameron Inhibition of Nitric Oxide Synthesis Potentiates Hypertension During Chronic Glucose Infusion in Rats Hypertension, January 1, 2000; 35(1): 451 - 456. [Abstract] [Full Text] [PDF]

				D. Y. Tan, S. Meng, and R. D. Manning Jr Role of Neuronal Nitric Oxide Synthase in Dahl Salt-Sensitive Hypertension Hypertension, January 1, 1999; 33(1): 456 - 461. [Abstract] [Full Text] [PDF]

				H. L. Keen, M. W. Brands, M. J. Smith Jr, and J. E. Hall Maintenance of Baseline Angiotensin II Potentiates Insulin Hypertension in Rats Hypertension, February 1, 1998; 31(2): 637 - 642. [Abstract] [Full Text] [PDF]

				M. W. Brands, D. L. Harrison, H. L. Keen, A. Gardner, E. W. Shek, and J. E. Hall Insulin-Induced Hypertension in Rats Depends on an Intact Renin-Angiotensin System Hypertension, April 1, 1997; 29(4): 1014 - 1019. [Abstract] [Full Text]